Publications by authors named "Emil Asprusten"

Claim this Profile
E
Efficacy and Safety of Oral PCSK9 Inhibitor Enlicitide in Adults With Heterozygous Familial Hypercholesterolemia: A Randomized Clinical Trial.
Christie M Ballantyne, Laura Gellis, Jean-Claude Tardif, Puja Banka, Ann Marie Navar, Emil Andreas Asprusten

JAMA· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular disease and compliance with lipid-lowering therapy among young individuals with familial hypercholesterolemia in Norway - A register study.
Gisle Langslet, Emil A Asprusten, Jannicke Igland, Kirsten B Holven, Martin P Bogsrud

Am J Prev Cardiol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A sterol panel for rare lipid disorders: sitosterolemia, cerebrotendinous xanthomatosis and Smith-Lemli-Opitz syndrome.
Alexander Bauer Westbye, Lili L Dizdarevic, Sandra R Dahl, Emil Andreas Asprusten, Yngve Thomas Bliksrud

J Lipid Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Missense mutation Q384K in the APOB gene affecting the large lipid transfer module of apoB reduces the secretion of apoB-100 in the liver without reducing the secretion of apoB-48 in the intestine.
Thea Bismo Strøm, Emil Asprusten, Jon K Laerdahl, Irene Øygard, M Mahmood Hussain

J Clin Lipidol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High levels of lipoprotein(a) - assessment and treatment.
Tone Svilaas, Tor Ole Klemsdal, Martin Prøven Bogsrud, Asgeir Græsdal, Elisabeth Kleivhaug Vesterbekkmo, Emil Andreas Asprusten

Tidsskr Nor Laegeforen· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Correction: High levels of lipoprotein(a) – assessment and treatment].
Tone Svilaas, Tor Ole Klemsdal, Martin Prøven Bogsrud, Asgeir Græsdal, Elisabeth Kleivhaug Vesterbekkmo, Emil Andreas Asprusten

Tidsskr Nor Laegeforen· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis